Forward Looking Statements
The following discussion contains “forward-looking statements,” including statements regarding expectations, beliefs, intentions or strategies for the future. These statements may identify important factors which could cause our actual results to differ materially from those indicated by the forward-looking statements. Given these uncertainties, readers are cautioned not to place undue reliance on such forward-looking statements. Factors that could cause our actual results to differ materially from those expressed or implied in such forward-looking statements include, but are not limited to:
| • | our history of losses and needs for additional capital to fund our operations and our ability to obtain additional capital on acceptable terms, or at all; |
| • | our dependence on the success of our initial product candidate, including OcuRing™-K and the commercialization of the DeepSolar solution; |
| • | the outcomes of preclinical studies, clinical trials and other research regarding OcuRing and PRF-110; |
| • | our limited experience managing clinical trials; |
| • | our ability to retain key personnel and recruit additional employees; |
| • | our reliance on third parties for the conduct of clinical trials, product manufacturing and development; |
| • | the impact of competition and new technologies; |
| • | our ability to comply with regulatory requirements relating to the development and marketing of our product candidates; |
| • | our ability to establish and maintain strategic partnerships and other corporate collaborations; |
| • | the implementation of our business model and strategic plans for our business and product candidates; |
| • | the scope of protection we are able to establish and maintain for intellectual property rights covering our product candidates and our ability to operate our business without infringing the intellectual property rights of others; |
| • | the overall global economic environment; |
| • | our ability to maintain compliance with Nasdaq’s continued listing requirements, including the minimum shareholders’ equity and minimum Market Value of Listed Securities (MVLS) requirements, and to maintain the listing of our ordinary shares on Nasdaq; |
| • | our ability to develop an active trading market for our ordinary shares and whether the market price of our ordinary shares is volatile; |
| • | statements as to the impact of the political and security situation in Israel on our business, including due to the current security situation in Israel; and |
| • | those factors referred to in “Risk Factors” as well as in our most recent Annual Report on Form 20-F, or any updates in our Reports on Form 6-K, generally. |
All forward-looking statements attributable to us or persons acting on our behalf speak only as of the date of the Form 6-K to which this discussion is attached and are expressly qualified in their entirety by the cautionary statements included herein. We undertake no obligations to update or revise forward-looking statements to reflect events or circumstances that arise after the date made or to reflect the occurrence of unanticipated events. In evaluating forward-looking statements, you should consider these risks and uncertainties.
